Written questions by Carden.

What steps his Department is taking to improve the (a) supply and (b) availability of ADHD medications.

The Department has been working hard with industry to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. As a result of our intensive work, some issues have been resolved. Many strengths of lisdexamfetamine and all strengths of atomoxetine capsules and guanfacine prolonged-release tablets are now available. We are working to resolve medicine supply issues, where they remain, for some strengths of lisdexamfetamine and methylphenidate. These are anticipated to resolve by August and October 2024, respectively.We have engaged with all suppliers of methylphenidate prolonged-release tablets to discuss the challenges faced and their actions to address them. We are asking suppliers to secure additional stocks, expedite deliveries where possible, and review plans to further build capacity to support continued growth in demand for the short and long-term.The Department has worked with specialist clinicians to develop management advice for National Health Service clinicians to consider prescribing available alternative brands of methylphenidate prolonged-release tablets. We would expect ADHD service providers and specialists to follow our guidance to offer rapid response to primary care teams seeking urgent advice or opinion for the management of patients including those known to be at a higher risk of adverse impact because of these shortages.To aid ADHD service providers and prescribers further, we have widely disseminated our communications and continually update a list of currently available and unavailable ADHD products on the Specialist Pharmacy Service website, helping ensure that those involved in the prescribing and dispensing of ADHD medications can make informed decisions with patients, which is available at the following link:https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/

Whether her Department plans to reform the SEND system.

For too long the education and care system has not meet the needs of all children, particularly those with special educational needs and disabilities (SEND), with parents struggling to get their children the support they need and deserve. This government’s ambition is that all children and young people with SEND or in alternative provision receive the right support to succeed in their education and as they move into adult life. The department will be focusing on a community-wide approach, improving inclusivity and expertise in mainstream schools, and ensuring that special schools cater to those with the most complex needs. My right hon. Friend, the Secretary of State for Education, and I will work with families and education and care experts to deliver this in the best interests of our children.